A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The t(8;21)(q22;q22) translocation is one of the most common genetic abnormalities in acute myeloid leukemia (AML), identified in 15% of all cases of AML, including 40-50% of FAB M2 subtype and rare cases of M0, M1 and M4 subtypes. The most commonly known AML1-ETO fusion protein (full-length AML1-ETO) from this translocation has 752 amino acids and contains the N-terminal portion of RUNX1 (also known as AML1, CBFalpha2 or PEBP2alphaB), including its DNA binding domain, and almost the entire RUNX1T1 (also known as MTG8 or ETO) protein. Although alterations of gene expression and hematopoietic cell proliferation have been reported in the presence of AML1-ETO, its expression does not lead to the development of leukemia. Here, we report the identification of a previously unknown alternatively spliced isoform of the AML1-ETO transcript, AML1-ETO9a, that includes an extra exon, exon 9a, of the ETO gene. AML1-ETO9a encodes a C-terminally truncated AML1-ETO protein of 575 amino acids. Expression of AML1-ETO9a leads to rapid development of leukemia in a mouse retroviral transduction-transplantation model. More importantly, coexpression of AML1-ETO and AML1-ETO9a results in the substantially earlier onset of AML and blocks myeloid cell differentiation at a more immature stage. These results indicate that fusion proteins from alternatively spliced isoforms of a chromosomal translocation may work together to induce cancer development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the ETO domains that recruit corepressors are frequently deleted from the RUNX1-ETO leukemia fusion protein seen in primary AML cells.41,42”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [42]
Citations
Cites
The Transcriptional Landscape of the Mammalian Genome
Carninci, P., Kasukawa, T., Katayama, S., Gough, J., Frith, M. C., Maeda, N., Oyama, R., Ravasi, T., Lenhard, B., Wells, C., et al. (2005) · Science · doi:10.1126/science.1112014 · Cited by 3,499 · cited 1×
“The widespread existence of alternatively spliced forms of transcripts has only recently been recognized as a result of advances in mammalian genomic analysi”
BackgroundA clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 1×
“We performed hematopoietic progenitor population analysis in leukemic mice with multicolor staining as described previousl”
MethodIdentification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“We performed hematopoietic progenitor population analysis in leukemic mice with multicolor staining as described previousl”
MethodPear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3780 · Cited by 755
Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., & Ohki, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05933.x · Cited by 498
Higuchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.-J., & Downing, J. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00016-8 · Cited by 440 · cited 1×
“It is well known that the commonly studied full-length AE protein is not sufficient to induce leukemia in either human or mouse hematopoietic cell”
BackgroundYuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C. J., Burel, S. A., Lagasse, E., Weissman, I. L., Akashi, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171321298 · Cited by 431 · cited 1×
“Full-length AML1-ETO is specifically expressed in myeloid cells under the control of the MRP8 promoter in MRP8-AE transgenic mic”
BackgroundSelf-citationBethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice
Kogan, S. C., Ward, J. M., Anver, M. R., Berman, J. J., Brayton, C., Cardiff, R. D., Carter, J. S., de Coronado, S., Downing, J. R., Fredrickson, T. N., et al. (2002) · Blood · doi:10.1182/blood.v100.1.238 · Cited by 418 · cited 1×
“According to the classification of the hematopathology subcommittee of the Mouse Model of Human Cancers Consortium (MMHCC”
MethodOkuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.-J., van Deursen, J. M. A., Harada, H., & Downing, J. R. (1998) · Blood · doi:10.1182/blood.v91.9.3134 · Cited by 372
The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation
Meyers, S., Lenny, N., & Hiebert, S. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1974 · Cited by 368
Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marín-Padilla, M., Tenen, D. G., Speck, N. A., & Zhang, D.-E. (1997) · Nature Genetics · doi:10.1038/ng0397-303 · Cited by 346 · cited 1×
“, although AE has been reported to block AML1 function during embryonic developmen”
BackgroundSelf-citationAML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
Nucifora, G., & Rowley, J. (1995) · Blood · doi:10.1182/blood.v86.1.1.bloodjournal8611 · Cited by 324
Self-citationThe 8;21 translocation in leukemogenesis
Peterson, L. F., & Zhang, D.-E. (2004) · Oncogene · doi:10.1038/sj.onc.1207727 · Cited by 302
Self-citationAnalysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model
Rhoades, K. L., Hetherington, C. J., Harakawa, N., Yergeau, D. A., Zhou, L., Liu, L.-Q., Little, M.-T., Tenen, D. G., & Zhang, D.-E. (2000) · Blood · doi:10.1182/blood.v96.6.2108 · Cited by 257
Self-citationThe AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells
Mulloy, J. C., Cammenga, J., MacKenzie, K. L., Berguido, F. J., Moore, M. A. S., & Nimer, S. D. (2002) · Blood · doi:10.1182/blood.v99.1.15 · Cited by 208
Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., Takenaka, K., Mizuno, S., Gondo, H., Okamura, T., et al. (1996) · Blood · doi:10.1182/blood.v87.11.4789.bloodjournal87114789 · Cited by 195
Role of RUNX family members in transcriptional repression and gene silencing
Durst, K. L., & Hiebert, S. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207122 · Cited by 184 · cited 7×
“To demonstrate the presence of the AE9a transcript, we performed RT-PCR using RNA prepared from the Kasumi-1 cell line (derived from an individual with t(8;21) AML), samples from 37 individuals with t(8;21), samples from 2 individuals with non-t(8;21) AML and samples from 2 individuals with t(8;21) in complete remissi…”
BackgroundMethodInfluentialAML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML
Licht, J. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204593 · Cited by 180
de Guzman, C. G., Warren, A. J., Zhang, Z., Gartland, L., Erickson, P., Drabkin, H., Hiebert, S. W., & Klug, C. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5506-5517.2002 · Cited by 171 · cited 7×
“To demonstrate the presence of the AE9a transcript, we performed RT-PCR using RNA prepared from the Kasumi-1 cell line (derived from an individual with t(8;21) AML), samples from 37 individuals with t(8;21), samples from 2 individuals with non-t(8;21) AML and samples from 2 individuals with t(8;21) in complete remissi…”
BackgroundMethodInfluentialSchwieger, M., Löhler, J., Friel, J., Scheller, M., Horak, I., & Stocking, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020824 · Cited by 143
Yan, M., Burel, S. A., Peterson, L. F., Kanbe, E., Iwasaki, H., Boyapati, A., Hines, R., Akashi, K., & Zhang, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406702101 · Cited by 137
Self-citationRhoades, K. L., Hetherington, C. J., Rowley, J. D., Hiebert, S. W., Nucifora, G., Tenen, D. G., & Zhang, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11895 · Cited by 129 · cited 1×
“De-identified AML patient samples were used to prepare RNA as previously describe”
MethodSelf-citationIncidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials
Langabeer, S. E., Walker, H., Rogers, J. R., Burnett, A. K., Wheatley, K., Swirsky, D., Goldstone, A. H., Linch, D. C., & Party, O. B. O. T. M. A. L. W. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4663270.x · Cited by 96 · cited 1×
“dtd" [ ]> The t(8;21)(q22;q22) translocation is one of the most common genetic abnormalities in acute myeloid leukemia (AML), identified in 15% of all cases of AML, including 40–50% of FAB M2 subtype and rare cases of M0, M1 and M4 subtype”
BackgroundStructure and expression of the human MTG8/ETO gene
DiStefano, J. K., & Procházka, M. (1998) · Gene · doi:10.1016/s0378-1119(98)00141-3 · Cited by 86
Rege, K., Swansbury, G. J., Atra, A., Horton, C., Min, T., Dainton, M., Matutes, E., Durosinmi, M. A., Treleaven, J. G., Powles, R., et al. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009054882 · Cited by 70 · cited 1×
“dtd" [ ]> The t(8;21)(q22;q22) translocation is one of the most common genetic abnormalities in acute myeloid leukemia (AML), identified in 15% of all cases of AML, including 40–50% of FAB M2 subtype and rare cases of M0, M1 and M4 subtype”
BackgroundRowe, D., Cotterill, S. J., Ross, F. M., Bunyan, D. J., Vickers, S. J., Bryon, J., McMullan, D. J., Griffiths, M. J., Reilly, J. T., Vandenberghe, E. A., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02474.x · Cited by 60
AML1/CBFβ transcription complex: its role in normal hematopoiesis and leukemia
Downing, J. R. (2001) · Leukemia · doi:10.1038/sj.leu.2402035 · Cited by 52
Peterson, L. F., Boyapati, A., Ranganathan, V., Iwama, A., Tenen, D. G., Tsai, S., & Zhang, D.-E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10205-10219.2005 · Cited by 51 · cited 1×
“We performed protein lysate preparation, western blotting and immunoprecipitation analysis as previously describe”
MethodSelf-citationCellular Characteristics of Acute Myeloblasts Leukemia Associated with t(8;21)(q22;q22)
Kita, K., Shirakawa, S., & Kamadat, N. (1994) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199409056286 · Cited by 42
Bäsecke, J., Schwieger, M., Griesinger, F., Schiedlmeier, B., Wulf, G. G., Trümper, L. H. P., & Stocking, C. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400010767 · Cited by 39
Cited by
Function of alternative splicing
Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., & Soreq, H. (2005) · Gene · doi:10.1016/j.gene.2004.10.022 · Cited by 1,377
Function of alternative splicing
Kelemen, O., Convertini, P., Zhang, Z., Wen, Y., Shen, M., Falaleeva, M., & Stamm, S. (2013) · Gene · doi:10.1016/j.gene.2012.07.083 · Cited by 743
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Bracken, A. P., & Helin, K. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2736 · Cited by 523
Role of RUNX1 in hematological malignancies
Sood, R., Kamikubo, Y., & Liu, P. (2017) · Blood · doi:10.1182/blood-2016-10-687830 · Cited by 494
“Consequently, NF-kB signaling was activated in RUNX1CBFA2T1 cells.66 Dysregulation of tumor suppressors has been observed in RUNX1RUNX1T1 leukemia. p14ARF (CDKN2A) and NF1 expression were transcriptionally repressed through dominant inhibition of RUNX1 function.67,68 Antiapoptosis genes BCL2 and Bcl-xL are also direct…”
BackgroundInfluentialAnti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Glaser, S. P., Lee, E. F., Trounson, E., Bouillet, P., Wei, A., Fairlie, W. D., Izon, D. J., Zuber, J., Rappaport, A. R., Herold, M. J., et al. (2012) · Genes & Development · doi:10.1101/gad.182980.111 · Cited by 423
“…involving the Mll (mixed-lineage leukemia) gene (MLL-ENL and MLL-AF9, particularly found in infants or individuals that had previously been treated with topoisomerase inhibitors) (Ayton et al. 2004) or Aml1 gene (AML1-ETO9, found in ;15% of human AML cases) (Yan et al. 2006; Jiao et al. 2009).”
BackgroundMethodInfluential
Metadata
- Authors
- Yan, M., Kanbe, E., Peterson, L. F., Boyapati, A., Miao, Y., Wang, Y., Chen, I.-M., Chen, Z., Rowley, J. D., Willman, C. L., & Zhang, D.-E.
- Affiliations
- Scripps Research Institute (US)
- University of New Mexico (US)
- Soochow University (CN)
- University of Chicago (US)
- Corresponding author
- Zhang, Dong-Er
- Venue
- Nature Medicine
- Published
- 2006-07-30
- Volume
- 12
- Issue
- 8
- Pages
- 945-949
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2038583094
- Cited by
- 279
- References
- 30
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 14 · 2023: 17 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 16 · 2018: 15 · 2017: 19 · 2016: 16 · 2015: 18 · 2014: 13 · 2013: 18 · 2012: 16
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (F32HL079900)
- National Cancer Institute (CA 104509, R01CA096735, CA096735, R01CA104509)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- AML1-ETO fusion protein, alternative splicing, RUNX1, RUNX1T1, acute myeloid leukemia, leukemogenesis, myeloid differentiation
- MeSH terms
- RUNX1 Translocation Partner 1 Protein, Amino Acid Sequence, Animals, Cell Line, Chromosomes, Human, Pair 21, Chromosomes, Human, Pair 8, Disease Models, Animal, Exons, Humans, Mice, Inbred C57BL, Mice, Inbred Strains, Mice, Transgenic, Molecular Sequence Data, Neoplasm Transplantation, Retroviridae, Translocation, Genetic, Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, Alternative Splicing, Protein Structure, Tertiary, Jurkat Cells, Protein Isoforms, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.